Horobin Joanna
SEC-identified person · CIK 1560959 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Liquidia Corp LQDA | Director | filed 2021–2026 |
| Kymera Therapeutics, Inc. KYMR | Director | filed 2020–2024 |
| Vyant Bio, Inc. VYNT | Director | filed 2021–2023 |
| Liquidia Technologies Inc LQDA | Director | filed 2019–2020 |
| Idera Pharmaceuticals, INC. IDRA | SVP and Chief Medical Officer | filed 2015–2019 |
| Verastem, Inc. VSTM | Chief Medical Officer | filed 2012–2015 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.